COVID-19 vaccine co-inventor Vaccitech pops 13% (Nasdaq:VACC)

Vaccitech (Nasdaq:VACC), which co-invented the Oxford University/AstraZeneca COVID-19 vaccine, rose more than 13% intraday to break above its $17 IPO price for the first time.
Read More